-
1
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221-1231.
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
2
-
-
0037299949
-
Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region?
-
Farrell GC. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol. 2003;18:124-138.
-
(2003)
J Gastroenterol Hepatol
, vol.18
, pp. 124-138
-
-
Farrell, G.C.1
-
3
-
-
0023801758
-
Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury
-
Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 1988;95:1056-1062.
-
(1988)
Gastroenterology
, vol.95
, pp. 1056-1062
-
-
Diehl, A.M.1
Goodman, Z.2
Ishak, K.G.3
-
4
-
-
0025260531
-
Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
-
Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12:1106-1110.
-
(1990)
Hepatology
, vol.12
, pp. 1106-1110
-
-
Wanless, I.R.1
Lentz, J.S.2
-
5
-
-
0031947715
-
Steatohepatitis: A tale of two "hits"?
-
Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998;114:842-845.
-
(1998)
Gastroenterology
, vol.114
, pp. 842-845
-
-
Day, C.P.1
James, O.F.2
-
6
-
-
0141510580
-
The natural history of nonalcoholic fatty liver disease: A clinical histopathological study
-
Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol. 2003;98:2042-2047.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2042-2047
-
-
Harrison, S.A.1
Torgerson, S.2
Hayashi, P.H.3
-
7
-
-
4644297019
-
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
-
Fassio F, Alvarez E, Dominquez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology. 2004;40:820-826.
-
(2004)
Hepatology
, vol.40
, pp. 820-826
-
-
Fassio, F.1
Alvarez, E.2
Dominquez, N.3
Landeira, G.4
Longo, C.5
-
8
-
-
0025178612
-
The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
-
Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74-80.
-
(1990)
Hepatology
, vol.11
, pp. 74-80
-
-
Powell, E.E.1
Cooksley, W.G.2
Hanson, R.3
Searle, J.4
Halliday, J.W.5
Powell, L.W.6
-
9
-
-
85031779447
-
-
Farrell GC, George J, de la M, editors. Fatty liver disease: NASH and related disorders. Malden, MA: Blackwell Publishing;
-
McCullough AJ. The epidemiology and risk factors of NASH. In: Farrell GC, George J, de la M Hall P, McCullough AJ, editors. Fatty liver disease: NASH and related disorders. Malden, MA: Blackwell Publishing; 2005. p. 23-37.
-
(2005)
The epidemiology and risk factors of NASH
, pp. 23-37
-
-
McCullough, A.J.1
-
10
-
-
0043268063
-
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C
-
Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology. 2003;38:420-427.
-
(2003)
Hepatology
, vol.38
, pp. 420-427
-
-
Hui, J.M.1
Kench, J.G.2
Chitturi, S.3
Sud, A.4
Farrell, G.C.5
Byth, K.6
-
11
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
-
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113-121.
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
St Sauver, J.3
Sanderson, S.O.4
Lindor, K.D.5
Feldstein, A.6
-
12
-
-
18544365700
-
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
-
Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 2002;35:1485-1493.
-
(2002)
Hepatology
, vol.35
, pp. 1485-1493
-
-
Ratziu, V.1
Bonyhay, L.2
Di Martino, V.3
Charlotte, F.4
Cavallaro, L.5
Sayegh-Tainturier, M.H.6
-
13
-
-
0035084699
-
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
-
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120:1183-1192.
-
(2001)
Gastroenterology
, vol.120
, pp. 1183-1192
-
-
Sanyal, A.J.1
Campbell-Sargent, C.2
Mirshahi, F.3
Rizzo, W.B.4
Contos, M.J.5
Sterling, R.K.6
-
14
-
-
1642377274
-
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes
-
Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004;350:664-671.
-
(2004)
N Engl J Med
, vol.350
, pp. 664-671
-
-
Petersen, K.F.1
Dufour, S.2
Befroy, D.3
Garcia, R.4
Shulman, G.I.5
-
15
-
-
0038025371
-
Mitochondrial dysfunction in the elderly: Possible role in insulin resistance
-
Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140-1142.
-
(2003)
Science
, vol.300
, pp. 1140-1142
-
-
Petersen, K.F.1
Befroy, D.2
Dufour, S.3
Dziura, J.4
Ariyan, C.5
Rothman, D.L.6
-
16
-
-
15444375341
-
Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling
-
Schattenberg JM, Wang Y, Singh R, Rigoli RM, Czaja MJ. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem. 2005;280:9887-9894.
-
(2005)
J Biol Chem
, vol.280
, pp. 9887-9894
-
-
Schattenberg, J.M.1
Wang, Y.2
Singh, R.3
Rigoli, R.M.4
Czaja, M.J.5
-
17
-
-
3543029821
-
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
-
Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem. 2004;279:32345-32353.
-
(2004)
J Biol Chem
, vol.279
, pp. 32345-32353
-
-
Samuel, V.T.1
Liu, Z.X.2
Qu, X.3
Elder, B.D.4
Bilz, S.5
Befroy, D.6
-
18
-
-
0037122801
-
-
Friedman J. Fat in all the wrong places. Nature. 2002;415:268-269.
-
Friedman J. Fat in all the wrong places. Nature. 2002;415:268-269.
-
-
-
-
19
-
-
4043077961
-
Molecular mediators of hepatic steatosis and liver injury
-
Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114:147-152.
-
(2004)
J Clin Invest
, vol.114
, pp. 147-152
-
-
Browning, J.D.1
Horton, J.D.2
-
20
-
-
3042744737
-
Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
-
Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology. 2004;40:46-54.
-
(2004)
Hepatology
, vol.40
, pp. 46-54
-
-
Hui, J.M.1
Hodge, A.2
Farrell, G.C.3
Kench, J.G.4
Kriketos, A.5
George, J.6
-
21
-
-
0031962882
-
DNA chips: An array of possibilities
-
Marshall A, Hodgson J. DNA chips: an array of possibilities. Nat Biotechnol. 1998;16:27-31.
-
(1998)
Nat Biotechnol
, vol.16
, pp. 27-31
-
-
Marshall, A.1
Hodgson, J.2
-
22
-
-
0036144678
-
Global gene expression analysis of gastric cancer by oligonucleotide microarrays
-
Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, Fukuyama M, et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002;62:233-240.
-
(2002)
Cancer Res
, vol.62
, pp. 233-240
-
-
Hippo, Y.1
Taniguchi, H.2
Tsutsumi, S.3
Machida, N.4
Chong, J.M.5
Fukuyama, M.6
-
23
-
-
0038005018
-
DAVID: Database for Annotation, Visualization, and Integrated Discovery
-
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3.
-
(2003)
Genome Biol
, vol.4
-
-
Dennis Jr, G.1
Sherman, B.T.2
Hosack, D.A.3
Yang, J.4
Gao, W.5
Lane, H.C.6
-
24
-
-
0037263812
-
MAPPFinder: Using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data
-
Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 2003;4:R7.
-
(2003)
Genome Biol
, vol.4
-
-
Doniger, S.W.1
Salomonis, N.2
Dahlquist, K.D.3
Vranizan, K.4
Lawlor, S.C.5
Conklin, B.R.6
-
25
-
-
0033569406
-
Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
-
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531-537.
-
(1999)
Science
, vol.286
, pp. 531-537
-
-
Golub, T.R.1
Slonim, D.K.2
Tamayo, P.3
Huard, C.4
Gaasenbeek, M.5
Mesirov, J.P.6
-
26
-
-
0038461088
-
Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis
-
Sreekumar R, Rosado B, Rasmussen D, Charlton M. Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology. 2003;38:244-251.
-
(2003)
Hepatology
, vol.38
, pp. 244-251
-
-
Sreekumar, R.1
Rosado, B.2
Rasmussen, D.3
Charlton, M.4
-
27
-
-
22844439963
-
Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis
-
Younossi ZM, Gorreta F, Ong JP, Schlauch K, Giacco LD, Elariny H, et al. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int. 2005;25:760-771.
-
(2005)
Liver Int
, vol.25
, pp. 760-771
-
-
Younossi, Z.M.1
Gorreta, F.2
Ong, J.P.3
Schlauch, K.4
Giacco, L.D.5
Elariny, H.6
-
28
-
-
27344435774
-
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
-
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545- 15550.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 15545-15550
-
-
Subramanian, A.1
Tamayo, P.2
Mootha, V.K.3
Mukherjee, S.4
Ebert, B.L.5
Gillette, M.A.6
-
29
-
-
0038054341
-
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
-
Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267-273.
-
(2003)
Nat Genet
, vol.34
, pp. 267-273
-
-
Mootha, V.K.1
Lindgren, C.M.2
Eriksson, K.F.3
Subramanian, A.4
Sihag, S.5
Lehar, J.6
-
30
-
-
10644220306
-
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
-
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395.
-
(2004)
Hepatology
, vol.40
, pp. 1387-1395
-
-
Browning, J.D.1
Szczepaniak, L.S.2
Dobbins, R.3
Nuremberg, P.4
Horton, J.D.5
Cohen, J.C.6
-
31
-
-
0030740659
-
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
-
Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997;27:103-107.
-
(1997)
J Hepatol
, vol.27
, pp. 103-107
-
-
Ueno, T.1
Sugawara, H.2
Sujaku, K.3
Hashimoto, O.4
Tsuji, R.5
Tamaki, S.6
-
32
-
-
0036072223
-
Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients
-
Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab. 2002;87:2784-2791.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 2784-2791
-
-
Miyazaki, Y.1
Mahankali, A.2
Matsuda, M.3
Mahankali, S.4
Hardies, J.5
Cusi, K.6
-
33
-
-
1442355447
-
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
-
Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology. 2004;39:188-196.
-
(2004)
Hepatology
, vol.39
, pp. 188-196
-
-
Promrat, K.1
Lutchman, G.2
Uwaifo, G.I.3
Freedman, R.J.4
Soza, A.5
Heller, T.6
-
34
-
-
0346374720
-
Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo
-
Saha AK, Avilucea PR, Ye JM, Assifi MM, Kraegen EW, Ruderman NB. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun. 2004;314:580-585.
-
(2004)
Biochem Biophys Res Commun
, vol.314
, pp. 580-585
-
-
Saha, A.K.1
Avilucea, P.R.2
Ye, J.M.3
Assifi, M.M.4
Kraegen, E.W.5
Ruderman, N.B.6
-
35
-
-
3242745192
-
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes
-
Tiikkainen M, Hakkinen AM, Korsheninnikova E, Nyman T, Makimattila S, Yki-Jarvinen H. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes. 2004;53:2169-2176.
-
(2004)
Diabetes
, vol.53
, pp. 2169-2176
-
-
Tiikkainen, M.1
Hakkinen, A.M.2
Korsheninnikova, E.3
Nyman, T.4
Makimattila, S.5
Yki-Jarvinen, H.6
-
36
-
-
0141532275
-
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone
-
Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology. 2003;38:1008-1017.
-
(2003)
Hepatology
, vol.38
, pp. 1008-1017
-
-
Neuschwander-Tetri, B.A.1
Brunt, E.M.2
Wehmeier, K.R.3
Oliver, D.4
Bacon, B.R.5
-
37
-
-
0027585532
-
Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography
-
Longo R, Ricci C, Masutti F, Vidimari R, Croce LS, Bercich L, et al. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993;28:297-302.
-
(1993)
Invest Radiol
, vol.28
, pp. 297-302
-
-
Longo, R.1
Ricci, C.2
Masutti, F.3
Vidimari, R.4
Croce, L.S.5
Bercich, L.6
-
38
-
-
19144365586
-
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
-
Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol. 2005;100:1082-1090.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1082-1090
-
-
Bugianesi, E.1
Gentilcore, E.2
Manini, R.3
Natale, S.4
Vanni, E.5
Villanova, N.6
-
39
-
-
33751545838
-
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
-
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med. 2006;355:2297-2307.
-
(2006)
N Engl J Med
, vol.355
, pp. 2297-2307
-
-
Belfort, R.1
Harrison, S.A.2
Brown, K.3
Darland, C.4
Finch, J.5
Hardies, J.6
-
40
-
-
14944359845
-
A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
-
Sanyal AJ, Mofrad PS, Contos MJ, Sargeant C, Luketic VA, Sterling RK, et al. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2004;2:1107-1115.
-
(2004)
Clin Gastroenterol Hepatol
, vol.2
, pp. 1107-1115
-
-
Sanyal, A.J.1
Mofrad, P.S.2
Contos, M.J.3
Sargeant, C.4
Luketic, V.A.5
Sterling, R.K.6
-
41
-
-
0034126755
-
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
-
Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr. 2000;136:734-738.
-
(2000)
J Pediatr
, vol.136
, pp. 734-738
-
-
Lavine, J.E.1
-
42
-
-
0034799895
-
Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: A pilot study
-
Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther. 2001;15:1667-1672.
-
(2001)
Aliment Pharmacol Ther
, vol.15
, pp. 1667-1672
-
-
Hasegawa, T.1
Yoneda, M.2
Nakamura, K.3
Makino, I.4
Terano, A.5
-
43
-
-
0344742265
-
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
-
Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2003;98:2485-2490.
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2485-2490
-
-
Harrison, S.A.1
Torgerson, S.2
Hayashi, P.3
Ward, J.4
Schenker, S.5
-
44
-
-
0033884107
-
Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parallel-group, placebo-controlled prospective clinical study
-
Miglio F, Rovati LC, Santoro A, Setnikar I. Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parallel-group, placebo-controlled prospective clinical study. Arzneimittelforschung. 2000;50:722-727.
-
(2000)
Arzneimittelforschung
, vol.50
, pp. 722-727
-
-
Miglio, F.1
Rovati, L.C.2
Santoro, A.3
Setnikar, I.4
-
45
-
-
0034834208
-
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study
-
Abdelmalek MF, Angulo P, Jorgensen RA, Sylvestre PB, Lindor KD. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol. 2001;96:2711-2717.
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2711-2717
-
-
Abdelmalek, M.F.1
Angulo, P.2
Jorgensen, R.A.3
Sylvestre, P.B.4
Lindor, K.D.5
-
46
-
-
1542515099
-
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
-
Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology. 2004;39:770-778.
-
(2004)
Hepatology
, vol.39
, pp. 770-778
-
-
Lindor, K.D.1
Kowdley, K.V.2
Heathcote, E.J.3
Harrison, M.E.4
Jorgensen, R.5
Angulo, P.6
-
47
-
-
33845336554
-
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis
-
Dufour JF, Oneta CM, Gonvers JJ, Bihl F, Cerny A, Cereda JM, et al. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2006;4:1537-1543.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 1537-1543
-
-
Dufour, J.F.1
Oneta, C.M.2
Gonvers, J.J.3
Bihl, F.4
Cerny, A.5
Cereda, J.M.6
-
48
-
-
4644305945
-
A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients
-
Harrison SA, Fincke C, Helinski D, Torgerson S, Hayashi P. A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients. Aliment Pharmacol Ther. 2004;20:623-628.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 623-628
-
-
Harrison, S.A.1
Fincke, C.2
Helinski, D.3
Torgerson, S.4
Hayashi, P.5
|